Blood Plasma Lipidomic Signature of Epicardial Fat in Healthy Obese Women

Sebastiano Collino, Martin Kussmann
Wiley-Blackwell, 2015
Journal paper

Abstract

ObjectivesA lipidomic approach was employed in a clinically well-defined cohort of healthy obese women to explore blood lipidome phenotype ascribed to body fat deposition, with emphasis on epicardial adipose tissue (EAT). MethodsThe present investigation delivered a lipidomics signature of epicardial adiposity under healthy clinical conditions using a cohort of 40 obese females (age: 25-45 years, BMI: 28-40 kg/m(2)) not showing any metabolic disease traits. Lipidomics analysis of blood plasma was employed in combination with in vivo quantitation of mediastinal fat depots by computerized tomography. ResultsAll cardiac fat depots correlated to indicators of hepatic dysfunctions (ALAT and ASAT), which describe physiological connections between hepatic and cardiac steatosis. Plasma lipidomics encompassed overall levels of lipid classes, fatty acid profiles, and individual lipid species. EAT and visceral fat associated with diacylglycerols (DAG), triglycerides, and distinct phospholipid and sphingolipid species. A pattern of DAG and phosphoglycerols was specific to EAT. ConclusionsHuman blood plasma lipidomics appears to be a promising clinical and potentially diagnostic readout for patient stratification and monitoring. Association of blood lipidomics signature to regio-specific mediastinal and visceral adiposity under healthy clinical conditions may help provide more biological insights into obese patient stratification for cardiovascular disease risks.

Official source

https://infoscience.epfl.ch/record/205409?ln=en

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Related concepts

Related publications

Kinetic reconstruction and analysis of sphingolipid metabolism

Vassily Hatzimanikatis, Howard Riezman, Georgios Savoglidis

Lipids are major constituents of the cell. They are responsible for major properties of the cellular membranes: hydrophobicity, selective permeability and being the scaffold of signaling proteins. Many diseases are associated with alterations in the lipid distribution in the cell and the composition of membrane domains. Metabolic syndrome, obesity, atherosclerosis, as well as Alzheimer’s, Huntington’s diseases and cancer, have an impact in the levels of lipids, with observed alterations in their concentrations compared to the healthy state. Applying computational techniques along with systematic modeling of lipid metabolism can provide insights that can guide biomedical research and develop potential strategies for prevention and cure. In the present study we developed a comprehensive model of the sphingolipid biosynthesis in the yeast Saccharomyces cerevisiae. Sphingolipids are one of the four major lipid categories, along with (glycero)phospholipids, sterols and fatty acids synthesized in the yeast S. cerevisiae. The importance of sphingolipids present in any higher eukaryote has been demonstrated in many recent studies. For this study, S. cerevisiae has been chosen as a model organism due to its high homology of cellular processes with mammalian cells. The developed model will be an essential part towards the construction of a detailed kinetic model of the whole lipidome of the cell. We first constructed a stoichiometric model that contains all the currently known reactions for the biosynthesis of ceramides and complex sphingolipids in the yeast. Additionally, we have accounted for all five reported hydroxylation states, along with the reactions synthesizing the necessary precursor metabolites from other lipid pathways (i.e. palmitate-CoA from fatty acid synthesis and phosphatidylinositol from the phospholipids metabolism). We next developed a kinetic model and we used a large number of lipidomic measurements of wild type yeast to consistently calibrate our model. Curation of the kinetic information of the model came from the comprehensive mining of references for operation of the enzymes as well as ranges of kinetic parameters from online databases. These datasets created the pool for a sampling technique that accounts for the uncertainty in the parameters of the model. This lead to a robust dynamic model, containing mass balances for all the components of the biochemical network as well as terms that accounted for the dillution of these molecules in the cell due to growth. We performed a thorough kinetic analysis of the system by examining the impact of different assumptions in enzyme operation on the levels of ceramides and complex sphingolipids (e.g. substrate competition, (un)competitive inhibition). By applying the principles of Metabolic Control Analysis (MCA) we were able to quantify the effect of enzyme activities on the lipid profiles and we identified enzymes of the biochemical reaction network as efficient targets for metabolic engineering towards a desired state. We also applied a reverse engineering method and we were able to identify enzyme perturbations responsible for an observed altered state compared to the wild type cellular lipidomic profile. Such an approach could lead to the identification of genetic mutations by imploring the information containd within metabolomic measurements. Although we demonstrate the application of the method in models of lipid metabolism it is possible to be applied to biochemical systems of various parts of metabolism and sizes creating a modular platform for kinetic analysis of cellular operations.

2014

Cell-to-cell variability plays a key role in tissue patterning by setting initial asymmetry that primes cell fate decisions. Fluctuations in the activity of regulatory molecules can commit individual cells to divergent differentiation pathways, and cell-to-cell variability can diversify the response of an otherwise homogeneous cell community to its environment. Recent advances have provided scientists with tools to study the variability associated with individual cells. However, while single-cell data are available for genomes, transcriptomes and proteomes, they are scarce for metabolic products, such as lipids. Eukaryotic cells produce thousands of lipids â each potentially contributing to specific biological functions. Furthermore, a number of metabolic switches involving lipids have been described to occur in development and cell differentiation. Few studies have directly addressed cell-to-cell lipid variations in syngeneic cell populations suggesting that lipid heterogeneity contributes to the emergence of multicellular patterns. Nonetheless, lipid biologists have so far addressed lipidomes in bulk cell extracts or selected lipids at the single-cell level. Thus, how lipidomes vary from one cell to another and which cell-to-cell lipid variations have biological meaning remains to be defined. Recent developments have provided mass spectrometry with sufficient sensitivity to reveal molecules in few hundred copies, making single-cell lipidomics possible. A rapidly emerging technique with a potential use in single-cell lipidomics is imaging mass spectrometry. Here, we devised a high-resolution MALDI imaging mass spectrometry pipeline to study cell-to-cell variability of the lipidome of hundreds of primary dermal human fibroblasts. We found that sphingolipid metabolism shows high cell-to-cell heterogeneity and that specific sphingolipids mark distinct cell sub-populations: coined herein as âlipotypesâ. Furthermore, we found that fibroblast lipotypes correspond to cell states endowed with proliferative, inflammatory or fibrogenic properties. Finally, we asked whether lipotypes participate in the specification of cell states and find that specific glycosphingolipids modulate signalling pathways (i.e., the FGF and TGF-b) to shape the transcriptional cell landscape. In summary, through the use of single-cell omics techniques, we found that: (i) specific lipid metabolic segments (i.e., the sphingolipid pathways) have cell-to-cell variation; (ii) given lipid configurations mark discrete cell states; and (iii) sphingolipids modulate dermal fibroblast activation involved in wound healing and skin homeostasis. Altogether, this study is among the first to demonstrate the potential of MALDI-IMS for single-cell lipidomics and to reveal cell-to-cell lipidome heterogeneity. It also demonstrates a role for lipids in the determination of cell states and in tissue patterning and reveals a new regulatory component to the self-organization of multicellular systems.

EPFL2021

A computational framework for integration of lipidomics data into metabolic pathways

Noushin Hadadi, Vassily Hatzimanikatis, Marianne Seijo, Keng Cher Soh, Aikaterini Zisaki

Lipids are important compounds for human physiology and as renewable resources for fuels and chemicals. In lipid research, there is a big gap between the currently available pathway-level representations of lipids and lipid structure databases in which the number of compounds is expanding rapidly with high-throughput mass spectrometry methods. In this work, we introduce a computational approach to bridge this gap by making associations between metabolic pathways and the lipid structures discovered increasingly thorough lipidomics studies. Our approach, called NICELips (Network Integrated Computational Explorer for Lipidomics), is based on the formulation of generalized enzymatic reaction rules for lipid metabolism, and it employs the generalized rules to postulate novel pathways of lipid metabolism. It further integrates all discovered lipids in biological networks of enzymatic reactions that consist their biosynthesis and biodegradation pathways. We illustrate the utility of our approach through a case study of bis(monoacylglycero)phosphate (BMP), a biologically important glycerophospholipid with immature synthesis and catabolic route(s). Using NICELips, we were able to propose various synthesis and degradation pathways for this compound and several other lipids with unknown metabolism like BMP, and in addition several alternative novel biosynthesis and biodegradation pathways for lipids with known metabolism. NICELips has potential applications in designing therapeutic interventions for lipid-associated disorders and in the metabolic engineering of model organisms for improving the biobased production of lipid-derived fuels and chemicals.

Academic Press Inc Elsevier Science2014

Kinetic reconstruction and analysis of sphingolipid metabolism

Vassily Hatzimanikatis, Howard Riezman, Georgios Savoglidis

2014

EPFL2021